AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...

Among the field of 30,000 athletes competing in Monday’s Boston Marathon are some familiar names, including local sports ...

The Ice Bucket Challenge, reimagined by USC students, raises funds and sparks conversations about mental health, aiming to ...

A new ice bucket fundraiser called the USC Speak Your Mind Challenge is spreading mental health awareness on TikTok and ...

Amyotrophic lateral sclerosis (ALS) is a relatively rare but very serious disease of the nervous system. A cure is not yet ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

When actor Eric Dane revealed his diagnosis of amyotrophic lateral sclerosis (ALS), the world took notice. Novant Health ...

The “Euphoria” actor says he is grateful to have his family by his side as he navigates the next chapter of his life.

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

A Series in The Lancet Neurology provides state-of-the-art reviews covering clinical and scientific evidence on the four most common genetic subtypes of amyotrophic lateral sclerosis (ALS), caused by ...

Neurosense Therapeutics’ PrimeC significantly reduces blood levels of miRNAs linked to amyotrophic lateral sclerosis, trial ...

Every year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease. There are few ...